Department of Pathology and Immunology, University of Geneva, Faculty of Medicine, Geneva, Switzerland.
Division of Rheumatology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Methods Mol Biol. 2023;2691:263-277. doi: 10.1007/978-1-0716-3331-1_21.
The interleukin (IL)-18 cytokine plays an important driver role in a range of autoimmune and inflammatory diseases, as well as cancer. IL-18 is a potent inducer of interferon gamma (IFN-γ), and the bioactivity of IL-18 is regulated by its natural soluble inhibitor, IL-18-binding protein (IL-18BP), which is present at high concentrations in the circulation. Many cell types have been described to secrete IL-18BP, constitutively or under the influence of IFN-γ, thus generating a negative feedback loop for IL-18. Therefore, solely measuring total IL-18 protein levels does not allow to evaluate its biological activity, especially in the context of systemic inflammatory diseases or other circumstances where IL-18BP is present (e.g., samples containing plasma, cells constitutively expressing IL-18BP). Considering there is a critical need to accurately measure the protein levels of both mature, biologically active IL-18 and IL-18BP as biomarkers of disease activity in patients and also stratification for potential anti-IL-18 therapy, in this chapter we provide the latest techniques to measure mature, free, and bioactive IL-18 and IL-18BP in different samples.
白细胞介素 (IL)-18 细胞因子在一系列自身免疫和炎症性疾病以及癌症中发挥着重要的驱动作用。IL-18 是干扰素 γ (IFN-γ) 的强效诱导剂,其生物活性受其天然可溶性抑制剂 IL-18 结合蛋白 (IL-18BP) 调节,IL-18BP 在循环中以高浓度存在。许多细胞类型被描述为分泌 IL-18BP,无论是在 IFN-γ 的影响下还是在其影响下,从而产生针对 IL-18 的负反馈回路。因此,仅测量总 IL-18 蛋白水平并不能评估其生物学活性,尤其是在系统性炎症性疾病或其他存在 IL-18BP 的情况下(例如,包含血浆的样本、持续表达 IL-18BP 的细胞)。考虑到迫切需要准确测量成熟、具有生物活性的 IL-18 和 IL-18BP 作为患者疾病活动的生物标志物的蛋白水平,以及潜在的抗 IL-18 治疗的分层,在本章中,我们提供了测量不同样本中成熟、游离和生物活性的 IL-18 和 IL-18BP 的最新技术。